
Sign up to save your podcasts
Or


Ben Wiegand, global head of the World without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent a disease or to identify it in its earliest stages for more effective treatments.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Scientific American4.2
599599 ratings
Ben Wiegand, global head of the World without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent a disease or to identify it in its earliest stages for more effective treatments.
Learn more about your ad choices. Visit megaphone.fm/adchoices

215 Listeners

83 Listeners

52 Listeners

1,381 Listeners

599 Listeners

756 Listeners

945 Listeners

76 Listeners

59 Listeners

544 Listeners

965 Listeners

410 Listeners

818 Listeners

6,467 Listeners

331 Listeners

363 Listeners

374 Listeners

44 Listeners

6,592 Listeners

116 Listeners

497 Listeners